AngioDynamics (ANGO) Misses Q1 EPS by 4c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
AngioDynamics Reports Fiscal 2023 First Quarter Financial Results; Reaffirms Guidance
October 6, 2022 7:00 AM EDTFiscal Year 2023 First Quarter Highlights
Net sales of $81.5 million increased 5.9% compared to the prior-year quarter Med Tech net sales of $22.8 million increased 29.6% Med Device net sales of $58.7 million decreased 1.1% Gross margin of 51.9% declined 20 basis points year over year GAAP loss per share of $0.33 and adjusted loss per share of $0.06 The Company commenced the Full Market Release of the AlphaVac F18 Mechanical Thrombectomy deviceLATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ:... More
